← Leaderboards
Daniel I Sessler
University Of Louisville
$2,536,866
Attributed
$4,641,854
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,641,854 · 6
By mechanism
R44$1,904,562 · 1
R42$1,498,909 · 1
R01$631,004 · 2
R34$597,379 · 1
R13$10,000 · 1
Top collaborators
- Karsten Bartels3 shared
- Kenneth R. Diller2 shared
- Anne Christie Fernandez2 shared
- Peter Jeffrey Rix2 shared
Most similar at University Of Louisville
Same institution · by research overlap
- John A Auchampach$10,409,762
- Catherine J Binkley$3,698,582
- Ozan Akca$254,077
- Edwin B Liem$404,250
- Jorge G Gomez-Gutierrez$1,600,393
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignClinical ResearchHuman SubjectOperative Surgical ProceduresPerioperativeGrantGeneral AnesthesiaAnesthesia ComplicationSamplingPostoperative ComplicationsWound InfectionEnsureTechnologyNational Institute Of Drug AbuseCollaborationsBody TemperatureValidationCostMedicineInstitutionBaseInnovationLocationOutcomes Research
Grant awards (12)
Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: AllUsCare$266,550
R34 · FY2025 · AA
Leveraging Alcohol Use Disorder Screening for Treatment in Routine Perioperative Care: AllUsCare$330,829
R34 · FY2024 · AA
Abuse-deterrence and prevention of respiratory depression by an oral opioid analgesic and doxapram combination$511,409
R44 · FY2023 · DA
Abuse-deterrence and prevention of respiratory depression by an oral opioid analgesic and doxapram combination$1,393,153
R44 · FY2022 · DA
Cardiovascular Outcomes Research in Perioperative Medicine - COR-PM$10,000
R13 · FY2022 · HL
Testing and Commercialization of a Superior Device to Maintain Perioperative Normothermia In Anesthetized Patients$520,015
R42 · FY2019 · GM · contact PI
Testing and Commercialization of a Superior Device to Maintain Perioperative Normothermia In Anesthetized Patients$978,894
R42 · FY2018 · GM · contact PI
Nitrous Oxide and Wound Infections$110,250
R01 · FY2005 · GM
Nitrous Oxide and Wound Infections$109,938
R01 · FY2004 · GM
Nitrous Oxide and Wound Infections$109,188
R01 · FY2003 · GM
SUPPLEMENTAL OXYGEN AND SURGICAL WOUND INFECTIONS$151,910
R01 · FY2001 · GM
SUPPLEMENTAL OXYGEN AND SURGICAL WOUND INFECTIONS$149,718
R01 · FY2000 · GM